Nephrology
| IgA nephropathy
Nephrology
IgA nephropathy
ENVISION Exploratory Analysis: Sibeprenlimab Reduces Circulating Immune Complexes in IgAN
book_2
Source:
Kidney Week 2024. Oral Session.
calendar_today
Published on Medfyle:
November 2024
import_contacts
5
min
In this medfyle
Deposition of IgA-containing circulating immune complexes in the kidney is a hallmark of IgAN. Exploratory data presented at Kidney Week 2024 show the anti-APRIL antibody sibeprenlimab reduces these complexes, and correlates with reductions in UPCR.
About this Medfyle
Read more
arrow_downward
Hide
arrow_upward
©2024 Infomedica-Medfyle. All rights reserved.
Source: The Anti-APRIL Antibody Sibeprenlimab Reduces Circulating Immune Complexes in Patients with IgAN: The Phase 2 ENVISION Randomized Controlled Trial. Barratt J, et al. Presented at Kidney Week 2024; #FR-OR59.
The information and data provided is for information purposes only. The author(s) of the original original presentation had no involvement in the creation of this content.
